Last update 01 Nov 2024
Guangzhou Runer Ophthalmic Biotechnology Co., Ltd.
Private Company|
2020|
Guangdong Sheng, China
Last update 01 Nov 2024
Overview
Tags
Eye Diseases
Otorhinolaryngologic Diseases
Immune System Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
ZOC2019619滴眼液治疗原发性开角型青光眼或者高眼压症的多中心、随机、双盲、平行、安慰剂或者噻吗洛尔滴眼液对照的有效性和安全性的Ⅱ期临床研究
[Translation] A phase II clinical study on the efficacy and safety of ZOC2019619 eye drops in the treatment of primary open-angle glaucoma or ocular hypertension: a multicenter, randomized, double-blind, parallel, placebo- or timolol eye drops-controlled study
一项评价ZOC2017217滴眼液在老年性白内障患者中有效性和安全性的多中心、随机、双盲、阳性药对照的II期临床研究
[Translation] A multicenter, randomized, double-blind, active-controlled Phase II clinical study to evaluate the efficacy and safety of ZOC2017217 eye drops in patients with senile cataract
0.05%盐酸依匹斯汀滴眼液治疗中国过敏性结膜炎患者的有效性和安全性的随机、双盲、阳性药平行对照、多中心临床研究
[Translation] A randomized, double-blind, positive-drug parallel-controlled, multicenter clinical study on the efficacy and safety of 0.05% epinastine hydrochloride eye drops in the treatment of allergic conjunctivitis in Chinese patients
100 Clinical Results associated with Guangzhou Runer Ophthalmic Biotechnology Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Guangzhou Runer Ophthalmic Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Guangzhou Runer Ophthalmic Biotechnology Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 07 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 2 Clinical
2
1
Phase 3 Clinical
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free